http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101660544-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2009-04-28^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-09-27^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-09-27^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101660544-B1 |
titleOfInvention | Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods |
abstract | The present invention relates generally to methods for in vitro diagnostics, particularly fibroblast growth factor 23 (FGF23), inorganic phosphorus (P), inorganic phosphorus and total calcium product (P x tCa), osteopontin (OPN) and parathyroid hormone ≪ / RTI > as a biomarker. The biomarker can be used to monitor the occurrence of fibroblast growth factor receptor (FGFR) kinase activity, particularly its inhibition, and / or the occurrence of secondary effects of FGFR inhibition. The present invention further provides methods and kits related to this use. |
priorityDate | 2008-04-29^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 237 of 237.